“RZ-001,” a Breakthrough Anti-Cancer Drug by Rznomics, Accelerates FDA Fast Track for Brain Cancer Therapy
“RZ-001", an anti-cancer drug developed by Rznomics Inc. (CEO Lee Seong-wook), has been designated by the U.S. Food and Drug ...
Tag: Rznomics
